<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
CLRB
Cellectar Biosciences
$
()


  • Cellectar Biosciences price target raised by $8 at Roth MKM, here's why

    3/28/2024 - 08:18am
  • Cellectar Biosciences price target raised by $1 at Oppenheimer, here's why

    3/28/2024 - 07:43am
  • Cellectar Bio reports 'impressive' efficacy in Phase 1 trial, says Roth MKM

    3/4/2024 - 11:50am
  • Cellectar Biosciences reports results from Phase 1 study of iopofosine I 131

    3/4/2024 - 06:43am
  • Biotech Alert: Searches spiking for these stocks today

    1/31/2024 - 10:56am
  • One new option listing and two option delistings on January 31st

    1/31/2024 - 08:30am
  • Cellectar Biosciences enrolls first patient in pediatric glioma Phase 1b study

    1/30/2024 - 06:45am
  • Cellectar Biosciences' iopofosine conjugate shows efficacy in CNS malignancies

    1/22/2024 - 06:44am
  • Cellectar announces preclinical data for CLR 121225

    1/16/2024 - 06:41am
  • Biotech Alert: Searches spiking for these stocks today

    1/11/2024 - 11:25am
  • Cellectar Biosciences partners with AON

    1/11/2024 - 06:42am
  • Biotech Alert: Searches spiking for these stocks today

    1/10/2024 - 11:12am
  • Cellectar Biosciences price target raised by $3 at Oppenheimer, here's why

    1/9/2024 - 07:31am
  • Cellectar Biosciences says CLOVER WaM study met its primary endpoint

    1/8/2024 - 06:42am
  • Cellectar Biosciences expands iopofosine I 131 collaboration with WARF

    12/19/2023 - 08:35am
dynamic_feed Breaking News